Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13412686 | 0.81 | MAPT (0.50) | POLBMEN1KMT2AGAATDP1 | |
| SCHEMBL14095057 | 0.81 | MAPT (0.50) | POLBMEN1KMT2AGAATDP1 | |
| SCHEMBL8582235 | 0.80 | ALDH1A1 (0.42) | POLBMEN1KMT2AGAATDP1 | |
| SCHEMBL8582231 | 0.80 | ALDH1A1 (0.42) | POLBMEN1KMT2AGAATDP1 | |
| SCHEMBL9393810 | 0.78 | POLB (0.39) | POLBMEN1KMT2AGAATDP1 | |
| SCHEMBL13855931 | 0.78 | POLB (0.39) | POLBMEN1KMT2AGAATDP1 | |
| SCHEMBL14095049 | 0.78 | POLB (0.39) | POLBMEN1KMT2AGAATDP1 | |
| SCHEMBL25246818 | 0.77 | ALDH1A1 (0.48) | POLBMEN1KMT2AGAATDP1 | |
| SCHEMBL7343451 | 0.76 | ALDH1A1 (0.39) | POLBMEN1KMT2AGAATDP1 | |
| SCHEMBL11252127 | 0.76 | ALDH1A1 (0.39) | POLBMEN1KMT2AGAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178601-B2 | Polymer film, polarizing plate protective film, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20090080074-A1 | POLYMER FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-03-26 | — | — | US | disclosed |
| US-20080204644-A1 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2008-08-28 | — | — | US | disclosed |
| US-20080192192-A1 | Optical film and polarizing plate | FUJIFILM CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090080074-A1 | POLYMER FILM, POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | RPA3, RTF1, RPA1 | POLB 1081/4885MEN1 2012/4885KMT2A 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.